MDPI雜志Molecules藥物載體專輯征稿(IF:3.267, 即時影響因子4.1)
Special Issue Information
Dear Colleagues,
Drug carriers including polymeric nanocarriers, lipid-based nanocarriers, inorganic nanocarriers and composite nanocarriers have been widely used to improve the effectiveness, selectivity and safety of various drugs. Benefiting from the great advances of biology, medicine, chemistry, materials science and nanotechnology, a growing number of drug carriers have been translated from bench to bedside. However, improvements in biodegradability, biocompatibility, immunogenicity, targeting ability, stimuli-responsiveness, and delivery efficiency of drug carriers remain needed to further facilitate the translation of nanomedicines and meet the new requirements of clinical applications.
This Special Issue aims to cover the recent outstanding advances in design and preparation of novel drug carriers with the ideal physicochemical and biological properties to improve the therapeutic outcomes of various therapeutic agents including chemotherapeutics, immunostimulatory molecules, nucleic acids, antibodies, tumor antigens and therapeutic proteins. It is our pleasure to invite you to contribute a manuscript to this Special Issue. Research articles, reviews, and short communications are all welcome.
Dr. Chunsheng Xiao
Guest Editor
Dr. Peng Zhang
Dr. Yu Zhang
Dr. Pan He
Dr. Mingqian Li
Assistant Guest Editors
網址鏈接:https://www.mdpi.com/journal/mol ... es/res_drug_carrier
歡迎各位同行投稿,如有意請站內私信留下聯系方式,編輯會給您發(fā)約稿郵件,還可享受版面費8折優(yōu)惠
返回小木蟲查看更多
京公網安備 11010802022153號
??
你
中科院的預警預警名單好像也沒有明確的評價標準,貌似也說明不了期刊的質量,我在Molecules上發(fā)過文章,審稿人給的意見都很中肯,編輯效率很高,整體投稿體驗很好
祝福
理解,聽說這個預警期刊名單只是試行,不知道后續(xù)發(fā)布頻率咋樣,評選標準會不會調整,目前名單感覺是在針對開源期刊,和國際趨向背道而馳了
,